BJ
GNCA

BlackRock Japan’s Genocea Biosciences, Inc. GNCA Stock Holding History

BlackRock Japan’s Portfolio GNCA Stock Details GNCA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-183
Closed -$10K – 1440
2015
Q3 		$10K Sell
183
-14
-7% -$1.39K ﹤0.01% 1173
2015
Q2 		$22K Sell
197
-230
-54% -$21.4K ﹤0.01% 1192
2015
Q1 		$40K Buy
+427
New +$30.1K ﹤0.01% 1102

Other funds holding GNCA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
PVMCV
Polaris Venture Management Co V Boston, Massachusetts $14.1M AUM 121.41% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Axa
Axa Paris, France $256M AUM 25.01% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return

BlackRock Japan's GNCA Position: Q4 2015 in Review

BlackRock Japan sold out of Genocea Biosciences, Inc. (GNCA) in Q4 2015, closing a stake of 183 shares — an estimated $10K sold.

BlackRock Japan first reported a position in GNCA in Q1 2015 and held it in 3 quarters. The position peaked at $40K in Q1 2015. 57 funds tracked by Wall St. Rank hold GNCA as of Q4 2015.

  • BlackRock Japan reported no remaining Genocea Biosciences, Inc. position as of Q4 2015 after selling out during the quarter.
  • BlackRock Japan sold 183 Genocea Biosciences, Inc. shares in Q4 2015, an estimated $10K.
  • BlackRock Japan first reported a position in Genocea Biosciences, Inc. in Q1 2015 and held it in 3 quarters.
  • BlackRock Japan's Genocea Biosciences, Inc. position peaked at $40K in Q1 2015.
  • 57 funds tracked by Wall St. Rank held Genocea Biosciences, Inc. as of Q4 2015.

Based on BlackRock Japan's 13F filing for Q4 2015, filed 11 Feb 2016.